✦ LIBER ✦

Second-line treatment of advanced measurable ovarian cancer with iproplatin: A Southwest oncology group study

✍ Scribed by Weiss, Geoffrey; Green, Stephanie; Alberts, David S.; Thigpen, James Tate; Hines, Harry E.; Hanson, Karl; Irving Pierce, H.; Baker, Laurence H.; Goodwin, John Wendall

Book ID: 122792453
Publisher: Elsevier Science
Year: 1991
Weight: 518 KB
Volume: 27
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(91)90470-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of carboplatin-cyclophosph

Phase I trial of carboplatin-cyclophosphamide and iproplatin-cyclophosphamide in advanced ovarian cancer: a Southwest Oncology Group study

✍ Alberts, David; Mason, Nancy; Surwit, Earl; Weiner, Sheldon; Hammond, Neel; Depp 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 594 KB

Phase II trial of amonafide in previousl

Phase II trial of amonafide in previously treated patients with advanced ovarian cancer: A Southwest Oncology Group study

✍ Holly H. Gallion; P.Y. Liu; David E. Alberts; Robert V. O'Toole; Janet O'Sulliva 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 320 KB

A Phase 2 Study with Epirubicin as Secon

A Phase 2 Study with Epirubicin as Second-Line Treatment of Patients with Advanced Epithelial Ovarian Cancer

✍ Hanne Havsteen; Kamma Bertelsen; Carl C. Gadeberg; Anders Jacobsen; Claus Kamby; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Phase II trial of vinblastine in previou

Phase II trial of vinblastine in previously treated patients with ovarian cancer: A Southwest Oncology Group study

✍ E.A. Surwit; D.S. Alberts; R.V. O'Toole; V. Graham; E.V. Hannigan; R.L. Stephens 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 386 KB

Phase II trial of vinblastine in previou

Phase II trial of vinblastine in previously treated patients with ovarian cancer: A southwest oncology group study

✍ E.A. Surwit; D.S. Alberts; R.V. O'Toole; V. Graham; E.V. Hannigan; R.L. Stephens 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 337 KB

Responsiveness of patients with advanced

Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A gynecologic oncology group study of second-line therapy in 105 patients

✍ Kenneth D. Hatch; Jackson B. Beecham; John A. Blessing; William T. Creasman 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 2 views